Ionis Pharmaceuticals shares are trading lower after the company priced its $500.3 million public offering of 11.5 million common shares at $43.50 per share.
Portfolio Pulse from Benzinga Newsdesk
Ionis Pharmaceuticals' stock is trading lower following the pricing of its $500.3 million public offering of 11.5 million common shares at $43.50 each.
September 10, 2024 | 11:33 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ionis Pharmaceuticals' shares are trading lower due to the pricing of its $500.3 million public offering of 11.5 million common shares at $43.50 per share.
The decrease in Ionis Pharmaceuticals' stock price is likely due to the dilution effect from the issuance of 11.5 million new shares at $43.50 each, which can lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100